ArticleMolecular cancer therapeutics2008

Nordihydroguaiaretic acid, a cytotoxic insulin-like growth factor-I receptor/HER2 inhibitor in trastuzumab-resistant breast cancer.

Danica L Rowe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.